Guido Kroemer discusses the possibility of using a non-invasive biomarker to measure autophagy in humans through the study of the redistribution of LC Three. Although there is still work to be done, a clinically relevant biomarker for autophagy could be a valuable tool for measuring the effects of fasting and other interventions.
